Items where Author is "Leuppi, J."
Number of items: 7. 2010Bernasconi, M. and Tamm, M. and Bingisser, R. and Miedinger, D. and Leuppi, J. and Muller, B. and Christ-Crain, M. and Stolz, D.. (2010) Midregional pro-atrial natriuretic peptide predicts survival in exacerbations of COPD. Chest, 140 (1). pp. 91-99. 2008Stolz, D. and Christ-Crain, M. and Morgenthaler, N. G. and Miedinger, D. and Leuppi, J. and Muller, C. and Bingisser, R. and Struck, J. and Muller, B. and Tamm, M.. (2008) Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD. Chest, 134 (2). pp. 263-272. Stolz, D. and Breidthardt, T. and Christ-Crain, M. and Bingisser, R. and Miedinger, D. and Leuppi, J. and Mueller, B. and Tamm, M. and Mueller, C.. (2008) Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD. Chest, 133 (5). pp. 1088-1094. Christ-Crain, M. and Breidthardt, T. and Stolz, D. and Zobrist, K. and Bingisser, R. and Miedinger, D. and Leuppi, J. and Tamm, M. and Mueller, B. and Mueller, C.. (2008) Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia. Journal of Internal Medicine, 264 (2). pp. 166-176. 2007Stolz, D. and Christ-Crain, M. and Bingisser, R. and Leuppi, J. and Miedinger, D. and Muller, C. and Huber, P. and Muller, B. and Tamm, M.. (2007) Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest, 131 (1). pp. 9-19. Stolz, D. and Christ-Crain, M. and Morgenthaler, N. G. and Leuppi, J. and Miedinger, D. and Bingisser, R. and Muller, C. and Struck, J. and Muller, B. and Tamm, M.. (2007) Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest, 131 (4). pp. 1058-1067. Muller, B. and Harbarth, S. and Stolz, D. and Bingisser, R. and Mueller, C. and Leuppi, J. and Nusbaumer, C. and Tamm, M. and Christ-Crain, M.. (2007) Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infectious Diseases, 7. p. 10. |